Myungin Haloperidol Injection

Adult dosage

○ Adults 1. Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, Tourette syndrome (Gilles de la Tourette's syndrome): Administer 6-15㎎ of this medicine per day by intramuscular injection in divided doses, and switch to oral administration as soon as possible. The dose may be adjusted appropriately according to age and symptoms. 2. Adjunctive treatment of postoperative nausea and vomiting when other medicines are ineffective or not tolerated: Administer haloperidol 1-2mg by intramuscular injection per dose.

This medication may increase the risk of death when used to treat psychotic symptoms in elderly patients with dementia, so caution is required. QT interval prolongation may lead to cardiac rhythm abnormalities or severe arrhythmias, thus patients with heart disease or related risk factors should be particularly cautious. Intravenous administration is not authorized; if administration is necessary, continuous monitoring of cardiac status via ECG is required. In patients at high risk of stroke, there may be an increased risk of cerebrovascular adverse reactions, hence it should be administered with care. There is a risk of venous thrombosis, so thromboembolic risk factors should be assessed and preventive measures taken before and during administration. When using ampoules, care should be taken to avoid glass particle contamination, especially in children and the elderly. Should not be used in patients with allergies to this drug or similar drugs, comatose state, alcohol dependence, severe heart failure, Parkinson's disease, specific dementias, bronchitis, and pregnant women. Dosage should be carefully adjusted for patients with impaired liver or kidney function, cardiovascular diseases, seizure disorders, thyroid diseases, patients on anticoagulants, children, and the elderly. This drug can cause various side effects, and symptoms such as heart problems, muscle rigidity, movement disorders, liver dysfunction, visual disturbances, allergic reactions, blood abnormalities, gastrointestinal issues, endocrine changes, respiratory problems, and neuropsychiatric symptoms may occur; if any abnormal symptoms appear, immediate consultation with healthcare providers is required. This medication may interact with other central nervous system depressants, antidepressants, antiarrhythmic drugs, warranting caution when used concurrently, and may alter blood concentrations when combined with certain drugs. Pregnant or breastfeeding women should not use this medication, as serious side effects may occur in neonates, especially in the late stages of pregnancy. The risk of movement disorders and hypotension increases in children and the elderly, requiring dosage adjustments and careful administration. In case of overdose, severe movement disorders, blood pressure abnormalities, and coma may occur, necessitating immediate emergency treatment. This injectable form is used only when oral administration is not feasible or in emergencies, and switching to oral administration as soon as possible is advisable.

increased mortality, acute death, QT prolongation, Torsades de Pointes, hypotension, hypertension, tachycardia, ventricular tachycardia, thromboembolism, motor paralysis, severe muscle rigidity, dysphagia, sweating, fever, leukocytosis, elevated serum CPK, myoglobinemia, renal impairment, high fever, altered consciousness, dyspnea, circulatory collapse, signs of dehydration, acute renal failure, acute muscle rigidity, opisthotonos, lockjaw, parkinsonian stiffness, tremor, immobility, inability to sit still, irreversible involuntary stereotypical movement disorder syndrome, withdrawal dyskinesia, hepatitis, jaundice, liver impairment, retinitis, cataract, accommodation disorder of the eye, blurred vision, corneal opacity, corneal pigmentation, edema, redness, urticaria, exfoliative dermatitis, photosensitivity, anaphylactic reaction, hypersensitivity vasculitis, bronchospasm, laryngospasm, anemia, leukocytosis, leukopenia, erythropenia, agranulocytosis, appetite loss, nausea, vomiting, constipation, diarrhea, intestinal paralysis, paralytic ileus, hyperprolactinemia, gynecomastia, galactorrhea, menstrual irregularities, changes in libido, hyperglycemia, hypoglycemia, weight gain, weight loss, hyponatremia, hypomolality, high urine output, seizures, altered consciousness, syndrome of inappropriate antidiuretic hormone secretion, bronchospasm, laryngeal spasm, dyspnea, insomnia, agitation, drowsiness, dizziness, headache, heaviness in the head, anxiety, depression, hallucination, agitation, thirst, nasal congestion, lethargy, urinary retention, fever, sweating, flushing, hypothermia

This medication may be sensitive to light, so it should be stored in a light-blocking, sealed container. Additionally, it is recommended to store the medication at room temperature, avoiding excessively hot or cold environments.

Appearance

Brown ampoules containing a colorless, transparent liquid.

Package unit

1 ampoule (1ml) x 10 pieces